Levels of inflammatory markers and their correlation with dyslipidemia in diabetics

Journal of the College of Physicians and Surgeons Pakistan

Volumn 19, Issue 4, 2009, Pages 207-210

  Waheed, Palvasha ^a   Naveed, Abdul Khaliq ^a   Farooq, Fareeha ^a  

^a ARMY MEDICAL COLLEGE   (Pakistan)

Author keywords

Diabetes mellitus; Dyslipidemia; High sensitivity C reactive protein; Serum ferritin

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DYSLIPIDEMIA; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; FERRITINS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; STATISTICS AS TOPIC; TRIGLYCERIDES; YOUNG ADULT;

EID: 65749099173     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007; 87:507-20.
2. Rivellese AA, Vaccaro O, Patti L. The pathophysiology of lipid metabolism and diabetes. Int J Clin Pract 2004; 58:32-5.
3. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444:860-7.
4. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999; 106:506-12.
5. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351:88-92.
6. Salonen JT, Tuomainen TP, Nyyssönen K, Lakka HM, Punnonen K. Relation between iron stores and non-insulin-dependent diabetes in men: case-control study. BMJ 1998; 317:727.
7. Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care 1999; 22: 1978-83.
8. Fernandez-Real JM, Ricart-Engel W, Arroyo E, Balanca R, Casamitjana-Abella R, Cabrero D, et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 1998; 21:62-8.
9. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, et al. Air Force/Texas coronary atherosclerosis prevention study investigators. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344:1959-65.
10. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286:327-34.
11. Nesto R. C-reactive protein, its role in inflammation, type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones. Diabet Med 2004; 21:810-17.
12. Rhee EJ, Kim YC, Lee WY, Jung CH, Sung KC, Ryu SH, et al. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans. Metabolism 2006; 55:183-7.
13. Sung KC, Kang JH, Shin HS. Relationship of cardiovascular risk factors and serum ferritin with C-reactive protein. Arch Med Res 2007; 38:121-5.
14. Barham D, Trinder P. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 1972; 97:142-5.
15. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6:24-7.
16. Mallia AK, Hermanson GT, Krohn RI, Fujimoto EK, Smith PK. Determination of glycosylated hemoglobin by affinity chromatography. Anal Letters 1981; 14:649-61.
17. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19:476-482.
18. Fossati R, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 28:2077-80.
19. Naito HK. Cholesterol. In: Kaplan LA, Pesce AJ, (edi). Clinical chemistry: theory, analysis, and correlation. St. Louis: CV. Mosby, 1984:p.437, 1194-1206.
20. Meiattini F, Prencipe L, Bardelli F, Giannini G, Tarli P. The 4-hydroxybenzoate/4-aminophenazone chromogenic system used in the enzymic determination of serum cholesterol. Clin Chem 1978; 24:2161-5.
21. Warnick GR, Wood PD. National Cholesterol Education Program. Recommendations for measurement of high-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on lipoprotein measurement. Clin Chem 1995; 41:1427-33.
22. Assman G. Lipiddiagnostik heute. In: Greten H, Lang PD, Schettler G. Lipoprotein und. Herzinfarkt, Germany: Witzstrock-Verlag. Baden-Baden (Germany); 1979:p.29.
23. Wellen KE, Hotamisligil GS. Inflammation, stress and diabetes. J Clin Invest 2005; 115: 1111-9.
24. Skowronski R, Hollenbeck CB, Varasteh BB, Chen YD, Reaven GM. Regulation of non-esterified fatty acid and glycerol concentration by insulin in normal individuals and patients with type 2 diabetes. Diabet Med 1991; 8:330-3.
25. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1991; 72: 96-107.
26. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 hours in patients with NIDDM. Diabetes 1988; 37: 1020-4.
27. Pihlajamäki J, Gylling H, Miettinen TA, Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 2004; 45: 507-12.
28. van Jaarsveld H, Pool GF, Barnard HC. Influence of ferritin levels on LDL cholesterol concentration in women. Res Commun Mol Pathol Pharmacol 1997; 98:201-8.